Anti-fibrotic effects of pirfenidone by interference with the hedgehog signalling pathway in patients with systemic sclerosis-associated interstitial lung disease

2018 ◽  
Vol 21 (2) ◽  
pp. 477-486 ◽  
Author(s):  
Hua Xiao ◽  
Guang-feng Zhang ◽  
Xiang-ping Liao ◽  
Xiao-jie Li ◽  
Jian Zhang ◽  
...  
Keyword(s):  
Systemic Sclerosis ◽  
Interstitial Lung Disease ◽  
Lung Disease ◽  
Signalling Pathway ◽  
Hedgehog Signalling ◽  
Hedgehog Signalling Pathway

scholarly journals Current and future perspectives on management of systemic sclerosis-associated interstitial lung disease

2019 ◽  
Vol 15 (10) ◽  
pp. 1009-1017 ◽  
Author(s):  
Oliver Distler ◽  
Elizabeth R. Volkmann ◽  
Anna Maria Hoffmann-Vold ◽  
Toby M. Maher
Keyword(s):  
Systemic Sclerosis ◽  
Interstitial Lung Disease ◽  
Lung Disease ◽  
Future Perspectives

scholarly journals Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

2019 ◽  
Vol 380 (26) ◽  
pp. 2518-2528 ◽  
Author(s):  
Oliver Distler ◽  
Kristin B. Highland ◽  
Martina Gahlemann ◽  
Arata Azuma ◽  
Aryeh Fischer ◽  
...  
Keyword(s):  
Systemic Sclerosis ◽  
Interstitial Lung Disease ◽  
Lung Disease
Sign in / Sign up

Export Citation Format

Share Document